Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global Payments
GPN
|
+$308M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$76.7M |
| 3 |
American Homes 4 Rent
AMH
|
+$69.4M |
| 4 |
Equinix
EQIX
|
+$51.2M |
| 5 |
Americold
COLD
|
+$48.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NiSource
NI
|
+$77.7M |
| 2 |
Linde
LIN
|
+$71M |
| 3 |
DTE Energy
DTE
|
+$57.1M |
| 4 |
Freeport-McMoran
FCX
|
+$51.7M |
| 5 |
FedEx
FDX
|
+$44.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.05% |
| 2 | Technology | 9.71% |
| 3 | Healthcare | 9.12% |
| 4 | Real Estate | 6.85% |
| 5 | Utilities | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Movado Group
MOV
$777M
| $508K | ﹤0.01% |
+18,930
| New | +$495K |
|
1352
Newell Brands
NWL
$2.53B
| $508K | ﹤0.01% |
+58,394
| New | +$581K |
|
1353
Algonquin Power & Utilities
AQN
$4.43B
| $507K | ﹤0.01% |
+61,368
| New | +$521K |
|
1354
Encore Capital Group
ECPG
$2.17B
| $503K | ﹤0.01% |
+10,343
| New | +$503K |
|
1355
Vaalco Energy
EGY
$602M
| $503K | ﹤0.01% |
+133,716
| New | +$546K |
|
1356
Sinclair Inc
SBGI
$1.06B
| $503K | ﹤0.01% |
36,376
-31,845
| -47% | -$526K |
|
1357
Innovative Industrial Properties
IIPR
$1.59B
| $501K | ﹤0.01% |
6,861
-4,129
| -38% | -$291K |
|
1358
The RMR Group
RMR
$336M
| $501K | ﹤0.01% |
21,632
+12,810
| +145% | +$299K |
|
1359
Hertz
HTZ
$795M
| $500K | ﹤0.01% |
+27,172
| New | +$445K |
|
1360
Ardelyx
ARDX
$976M
| $498K | ﹤0.01% |
+147,014
| New | +$603K |
|
|
BRKL
1361
DELISTED
Brookline Bancorp
BRKL
| $497K | ﹤0.01% |
56,877
+15,895
| +39% | +$145K |
|
1362
Southside Bancshares
SBSI
$951M
| $496K | ﹤0.01% |
+18,975
| New | +$552K |
|
|
REVG
1363
DELISTED
REV Group
REVG
| $495K | ﹤0.01% |
+37,338
| New | +$426K |
|
1364
Ironwood Pharmaceuticals
IRWD
$725M
| $492K | ﹤0.01% |
46,229
-425,794
| -90% | -$4.58M |
|
1365
Atlanta Braves Holdings Series B
BATRK
$3.4B
| $491K | ﹤0.01% |
+12,399
| New | +$466K |
|
1366
International Bancshares
IBOC
$4.4B
| $491K | ﹤0.01% |
11,111
+5,467
| +97% | +$238K |
|
1367
Ecopetrol
EC
$34.5B
| $490K | ﹤0.01% |
47,791
-52,765
| -52% | -$532K |
|
1368
Employers Holdings
EIG
$876M
| $488K | ﹤0.01% |
13,039
-9,700
| -43% | -$380K |
|
1369
LCI Industries
LCII
$2.55B
| $487K | ﹤0.01% |
+3,853
| New | +$441K |
|
1370
Vanda Pharmaceuticals
VNDA
$329M
| $486K | ﹤0.01% |
+73,822
| New | +$473K |
|
1371
Chewy
CHWY
$10.1B
| $485K | ﹤0.01% |
12,294
-92,371
| -88% | -$3.22M |
|
1372
Tilray
TLRY
$671M
| $485K | ﹤0.01% |
+31,060
| New | +$666K |
|
|
CERE
1373
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $485K | ﹤0.01% |
+15,245
| New | +$468K |
|
1374
Kinsale Capital Group
KNSL
$8.84B
| $483K | ﹤0.01% |
+1,291
| New | +$429K |
|
1375
Montauk Renewables
MNTK
$259M
| $482K | ﹤0.01% |
64,804
+16,904
| +35% | +$117K |
|
Similar funds
Michael Gelband's Q2 2023 Portfolio in Review
As of Q2 2023, Michael Gelband held 2,377 positions worth $12.3B, up 1.9% from $12.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Michael Gelband's Q2 2023 filing shows 669 new, 496 increased, 623 reduced and 582 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 364,360 shares worth $75.5M. The largest sale was NiSource, an estimated $77.7M.
By sector, the portfolio is most concentrated in Industrials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
- Michael Gelband's largest Q2 2023 buy was Pioneer Natural Resource Co.: 364,360 shares worth $75.5M.
- Michael Gelband added most to Global Payments in Q2 2023, an estimated $308M increase.
- Michael Gelband's biggest Q2 2023 reduction was NiSource, cutting an estimated $77.7M.
- Michael Gelband fully exited L3Harris in Q2 2023, selling an estimated $44.7M.
- Michael Gelband's ten largest holdings make up 25% of its $12.3B portfolio in Q2 2023.
- Michael Gelband opened 669 new positions and closed 582 in Q2 2023.
- Michael Gelband's portfolio value rose 1.9% quarter-over-quarter to $12.3B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.